Credit Suisse analyst John Roberts raised the firm’s price target on Albemarle to $240 from $200 and keeps an Underperform rating on the shares. The firm cites uncertain lithium pricing but solid volume growth outlook.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ALB:
- Albemarle’s (NYSE:ALB) Catalysts Business Takes a New Direction as a Subsidiary
- Albemarle launches Ketjen, a wholly owned subsidiary
- Albemarle price target raised to $325 from $300 at Mizuho
- Albemarle initiated with Overweight, $310 target at Piper Sandler
- Albemarle initiated with an Overweight at Piper Sandler
